日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Racial Disparities in Comorbidity Patterns of Early-Onset Liver Cancer: A Machine Learning Analysis

早期肝癌合并症模式的种族差异:机器学习分析

Ma, Bingya; Zheng, Kai; Lee, Fa-Chyi; Lu, Yunxia

Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer

遗传性癌症诊所提高了胰腺癌患者对NCCN胚系检测指南的遵循度

Rosso, Claudia; Marciano, Naomie Devico; Nathan, Deepika; Chen, Wen-Pin; McLaren, Christine E; Osann, Kathryn E; Flodman, Pamela L; Cho, May T; Lee, Fa-Chyi; Dayyani, Farshid; Zell, Jason A; Valerin, Jennifer B

A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitors

卡博替尼联合帕博利珠单抗治疗对免疫检查点抑制剂耐药或难治性晚期胃/胃食管腺癌的II期研究

Dayyani, Farshid; Chao, Joseph; Lee, Fa-Chyi; Taylor, Thomas H; Neumann, Kristen; Cho, May T

A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expression profiling

胃食管交界处肝样腺癌与睾丸生殖细胞肿瘤鉴别诊断挑战的病例报告:基因表达谱分析在改进诊断中的应用

Yazdanpanah, Omid; Lee, Fa-Chyi; Houshyar, Roozbeh; Nourbakhsh, Mahra; Mar, Nataliya

Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiation

病例报告:一例伴有鳞状细胞分化的胰腺癌患者获得完全病理缓解

Grant, Christopher R; Arter, Zhaohui L; Truc, Tran; Lee, Fa-Chyi

BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms

BRCA突变型胰腺癌:从发现到新型治疗模式

Devico Marciano, Naomie; Kroening, Gianna; Dayyani, Farshid; Zell, Jason A; Lee, Fa-Chyi; Cho, May; Valerin, Jennifer Goldstein

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

更正:评估口服福瑞替尼(GSK1363089,一种cMET/VEGFR2抑制剂)两种给药方案治疗转移性胃癌患者的II期研究

Shah, Manish A; Wainberg, Zev A; Catenacci, Daniel V T; Hochster, Howard S; Ford, James; Kunz, Pamela; Lee, Fa-Chyi; Kallender, Howard; Cecchi, Fabiola; Rabe, Daniel C; Keer, Harold; Martin, Anne-Marie; Liu, Yuan; Gagnon, Robert; Bonate, Peter; Liu, Li; Gilmer, Tona; Bottaro, Donald P

Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy

单药免疫治疗进展后,接受序贯双药免疫治疗的晚期胆管癌患者获得持久疗效

Kaakour, Dalia; Hagopian, Garo; Lee, Sonia; Lee, Fa Chyi

Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems

癌症治疗的经济毒性:三种不同医疗保健系统的财务负担分析

Divya A Parikh, Meera Ragavan, Ritika Dutta, Jeffrey Garnet Edwards, James Dickerson, Debeshi Maitra, Sangeeta Aggarwal, Fa-Chyi Lee, Manali I Patel

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer

MAVERICC 是一项随机、生物标志物分层的 II 期研究,旨在比较 mFOLFOX6-贝伐单抗与 FOLFIRI-贝伐单抗作为转移性结直肠癌一线化疗方案的疗效。

Parikh, Aparna R; Lee, Fa-Chyi; Yau, Linda; Koh, Han; Knost, James; Mitchell, Edith P; Bosanac, Ivan; Choong, Nicholas; Scappaticci, Frank; Mancao, Christoph; Lenz, Heinz-Josef